Loading…

Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes

A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active infection and the incidence of stroke increases during flu season. We and othe...

Full description

Saved in:
Bibliographic Details
Published in:Behavioral and brain functions 2015-10, Vol.11 (1), p.32-32, Article 32
Main Authors: Doll, Danielle N, Engler-Chiurazzi, Elizabeth B, Lewis, Sara E, Hu, Heng, Kerr, Ashley E, Ren, Xuefang, Simpkins, James W
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3
cites cdi_FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3
container_end_page 32
container_issue 1
container_start_page 32
container_title Behavioral and brain functions
container_volume 11
creator Doll, Danielle N
Engler-Chiurazzi, Elizabeth B
Lewis, Sara E
Hu, Heng
Kerr, Ashley E
Ren, Xuefang
Simpkins, James W
description A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active infection and the incidence of stroke increases during flu season. We and others have shown that the combination of a minor bacterial infection mimic, 100 μg/kg of lipopolysaccharide (LPS) prior to a minor stroke-30 min transient middle cerebral artery occlusion (tMCAO)-exacerbates infarct volume in a mouse model. Thus, experimental and epidemiological data strongly suggest that infection and/or inflammation play a role in stroke occurrence and severity. However, to date, long-term outcomes of stroke during an active infection has not been studied. 3-4 month old C57Bl6/J mice were treated with saline or LPS 30 min prior to a 30 min tMCAO or sham surgery. A behavioral battery was administered to assess health status/sickness behavior, neurological deficits, motor, cognitive, and affective behaviors. We show for the first time that exposure to a low dose of LPS prior to a mild stroke significantly worsens neurological deficits and sickness scores. Motor, cognitive, and affective behaviors were assessed post-stroke and while stroke significantly affected motor behavior on rotarod, LPS did not increase the motor deficits. We did not observe any effects of stroke or LPS on cognitive and affective behaviors. Our observations of the association between infection, stroke, and worse sickness and neurological outcomes identify (1) a clinical need to aggressively treat infections in people with risk factors for stroke and (2) the need to understand the mechanism(s) of the association between infections and stroke.
doi_str_mv 10.1186/s12993-015-0077-5
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4604642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4016749371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3</originalsourceid><addsrcrecordid>eNpdkU9vFDEMxSMEoqXwAbigSFy4DOTfJJkLEqpoQVqJC5yjbOJhU2YnQ5xpKZ-erLZUhZMtvecn2z9CXnL2lnOr3yEXwyA7xvuOMWO6_hE55UapbmCWP37Qn5BniFeMSauEeEpOhFZaWq1OSdikJS95ukUfws6XFIHCLx-gbH0FpGkefQmVYvoN1M-RFsB1qgeB3uSCMEOkS8baYS35B9At7Px1ysVPNK815D3gc_Jk9BPCi7t6Rr5dfPx6_qnbfLn8fP5h04Ve2NpZb1XvNehRbK2QRkrJBY_caKm0kd6Mwpsw2MhHYaIefROClL1WEGwUUZ6R98fcZd3uIQaYa1vDLSXtfbl12Sf3rzKnnfuer53STGklWsCbu4CSf66A1e0TBpgmP0Ne0XEjRHug6XWzvv7PepXXMrfzmssMxnIhWHPxoyuUjFhgvF-GM3dA6I4IXUPoDghd32ZePbzifuIvM_kHKoqZIQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779781220</pqid></control><display><type>article</type><title>Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Doll, Danielle N ; Engler-Chiurazzi, Elizabeth B ; Lewis, Sara E ; Hu, Heng ; Kerr, Ashley E ; Ren, Xuefang ; Simpkins, James W</creator><creatorcontrib>Doll, Danielle N ; Engler-Chiurazzi, Elizabeth B ; Lewis, Sara E ; Hu, Heng ; Kerr, Ashley E ; Ren, Xuefang ; Simpkins, James W</creatorcontrib><description>A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active infection and the incidence of stroke increases during flu season. We and others have shown that the combination of a minor bacterial infection mimic, 100 μg/kg of lipopolysaccharide (LPS) prior to a minor stroke-30 min transient middle cerebral artery occlusion (tMCAO)-exacerbates infarct volume in a mouse model. Thus, experimental and epidemiological data strongly suggest that infection and/or inflammation play a role in stroke occurrence and severity. However, to date, long-term outcomes of stroke during an active infection has not been studied. 3-4 month old C57Bl6/J mice were treated with saline or LPS 30 min prior to a 30 min tMCAO or sham surgery. A behavioral battery was administered to assess health status/sickness behavior, neurological deficits, motor, cognitive, and affective behaviors. We show for the first time that exposure to a low dose of LPS prior to a mild stroke significantly worsens neurological deficits and sickness scores. Motor, cognitive, and affective behaviors were assessed post-stroke and while stroke significantly affected motor behavior on rotarod, LPS did not increase the motor deficits. We did not observe any effects of stroke or LPS on cognitive and affective behaviors. Our observations of the association between infection, stroke, and worse sickness and neurological outcomes identify (1) a clinical need to aggressively treat infections in people with risk factors for stroke and (2) the need to understand the mechanism(s) of the association between infections and stroke.</description><identifier>ISSN: 1744-9081</identifier><identifier>EISSN: 1744-9081</identifier><identifier>DOI: 10.1186/s12993-015-0077-5</identifier><identifier>PMID: 26463864</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Affect - drug effects ; Animals ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Brain Infarction - pathology ; Brain Infarction - physiopathology ; Brain Infarction - psychology ; Cognition - drug effects ; Illness Behavior - drug effects ; Infarction, Middle Cerebral Artery - pathology ; Infarction, Middle Cerebral Artery - physiopathology ; Infarction, Middle Cerebral Artery - psychology ; Lipopolysaccharides - adverse effects ; Male ; Mice ; Rotarod Performance Test</subject><ispartof>Behavioral and brain functions, 2015-10, Vol.11 (1), p.32-32, Article 32</ispartof><rights>Copyright BioMed Central 2015</rights><rights>Doll et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3</citedby><cites>FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604642/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1779781220?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26463864$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Doll, Danielle N</creatorcontrib><creatorcontrib>Engler-Chiurazzi, Elizabeth B</creatorcontrib><creatorcontrib>Lewis, Sara E</creatorcontrib><creatorcontrib>Hu, Heng</creatorcontrib><creatorcontrib>Kerr, Ashley E</creatorcontrib><creatorcontrib>Ren, Xuefang</creatorcontrib><creatorcontrib>Simpkins, James W</creatorcontrib><title>Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes</title><title>Behavioral and brain functions</title><addtitle>Behav Brain Funct</addtitle><description>A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active infection and the incidence of stroke increases during flu season. We and others have shown that the combination of a minor bacterial infection mimic, 100 μg/kg of lipopolysaccharide (LPS) prior to a minor stroke-30 min transient middle cerebral artery occlusion (tMCAO)-exacerbates infarct volume in a mouse model. Thus, experimental and epidemiological data strongly suggest that infection and/or inflammation play a role in stroke occurrence and severity. However, to date, long-term outcomes of stroke during an active infection has not been studied. 3-4 month old C57Bl6/J mice were treated with saline or LPS 30 min prior to a 30 min tMCAO or sham surgery. A behavioral battery was administered to assess health status/sickness behavior, neurological deficits, motor, cognitive, and affective behaviors. We show for the first time that exposure to a low dose of LPS prior to a mild stroke significantly worsens neurological deficits and sickness scores. Motor, cognitive, and affective behaviors were assessed post-stroke and while stroke significantly affected motor behavior on rotarod, LPS did not increase the motor deficits. We did not observe any effects of stroke or LPS on cognitive and affective behaviors. Our observations of the association between infection, stroke, and worse sickness and neurological outcomes identify (1) a clinical need to aggressively treat infections in people with risk factors for stroke and (2) the need to understand the mechanism(s) of the association between infections and stroke.</description><subject>Affect - drug effects</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Brain Infarction - pathology</subject><subject>Brain Infarction - physiopathology</subject><subject>Brain Infarction - psychology</subject><subject>Cognition - drug effects</subject><subject>Illness Behavior - drug effects</subject><subject>Infarction, Middle Cerebral Artery - pathology</subject><subject>Infarction, Middle Cerebral Artery - physiopathology</subject><subject>Infarction, Middle Cerebral Artery - psychology</subject><subject>Lipopolysaccharides - adverse effects</subject><subject>Male</subject><subject>Mice</subject><subject>Rotarod Performance Test</subject><issn>1744-9081</issn><issn>1744-9081</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkU9vFDEMxSMEoqXwAbigSFy4DOTfJJkLEqpoQVqJC5yjbOJhU2YnQ5xpKZ-erLZUhZMtvecn2z9CXnL2lnOr3yEXwyA7xvuOMWO6_hE55UapbmCWP37Qn5BniFeMSauEeEpOhFZaWq1OSdikJS95ukUfws6XFIHCLx-gbH0FpGkefQmVYvoN1M-RFsB1qgeB3uSCMEOkS8baYS35B9At7Px1ysVPNK815D3gc_Jk9BPCi7t6Rr5dfPx6_qnbfLn8fP5h04Ve2NpZb1XvNehRbK2QRkrJBY_caKm0kd6Mwpsw2MhHYaIefROClL1WEGwUUZ6R98fcZd3uIQaYa1vDLSXtfbl12Sf3rzKnnfuer53STGklWsCbu4CSf66A1e0TBpgmP0Ne0XEjRHug6XWzvv7PepXXMrfzmssMxnIhWHPxoyuUjFhgvF-GM3dA6I4IXUPoDghd32ZePbzifuIvM_kHKoqZIQ</recordid><startdate>20151013</startdate><enddate>20151013</enddate><creator>Doll, Danielle N</creator><creator>Engler-Chiurazzi, Elizabeth B</creator><creator>Lewis, Sara E</creator><creator>Hu, Heng</creator><creator>Kerr, Ashley E</creator><creator>Ren, Xuefang</creator><creator>Simpkins, James W</creator><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151013</creationdate><title>Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes</title><author>Doll, Danielle N ; Engler-Chiurazzi, Elizabeth B ; Lewis, Sara E ; Hu, Heng ; Kerr, Ashley E ; Ren, Xuefang ; Simpkins, James W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Affect - drug effects</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Brain Infarction - pathology</topic><topic>Brain Infarction - physiopathology</topic><topic>Brain Infarction - psychology</topic><topic>Cognition - drug effects</topic><topic>Illness Behavior - drug effects</topic><topic>Infarction, Middle Cerebral Artery - pathology</topic><topic>Infarction, Middle Cerebral Artery - physiopathology</topic><topic>Infarction, Middle Cerebral Artery - psychology</topic><topic>Lipopolysaccharides - adverse effects</topic><topic>Male</topic><topic>Mice</topic><topic>Rotarod Performance Test</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Doll, Danielle N</creatorcontrib><creatorcontrib>Engler-Chiurazzi, Elizabeth B</creatorcontrib><creatorcontrib>Lewis, Sara E</creatorcontrib><creatorcontrib>Hu, Heng</creatorcontrib><creatorcontrib>Kerr, Ashley E</creatorcontrib><creatorcontrib>Ren, Xuefang</creatorcontrib><creatorcontrib>Simpkins, James W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Behavioral and brain functions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Doll, Danielle N</au><au>Engler-Chiurazzi, Elizabeth B</au><au>Lewis, Sara E</au><au>Hu, Heng</au><au>Kerr, Ashley E</au><au>Ren, Xuefang</au><au>Simpkins, James W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes</atitle><jtitle>Behavioral and brain functions</jtitle><addtitle>Behav Brain Funct</addtitle><date>2015-10-13</date><risdate>2015</risdate><volume>11</volume><issue>1</issue><spage>32</spage><epage>32</epage><pages>32-32</pages><artnum>32</artnum><issn>1744-9081</issn><eissn>1744-9081</eissn><abstract>A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active infection and the incidence of stroke increases during flu season. We and others have shown that the combination of a minor bacterial infection mimic, 100 μg/kg of lipopolysaccharide (LPS) prior to a minor stroke-30 min transient middle cerebral artery occlusion (tMCAO)-exacerbates infarct volume in a mouse model. Thus, experimental and epidemiological data strongly suggest that infection and/or inflammation play a role in stroke occurrence and severity. However, to date, long-term outcomes of stroke during an active infection has not been studied. 3-4 month old C57Bl6/J mice were treated with saline or LPS 30 min prior to a 30 min tMCAO or sham surgery. A behavioral battery was administered to assess health status/sickness behavior, neurological deficits, motor, cognitive, and affective behaviors. We show for the first time that exposure to a low dose of LPS prior to a mild stroke significantly worsens neurological deficits and sickness scores. Motor, cognitive, and affective behaviors were assessed post-stroke and while stroke significantly affected motor behavior on rotarod, LPS did not increase the motor deficits. We did not observe any effects of stroke or LPS on cognitive and affective behaviors. Our observations of the association between infection, stroke, and worse sickness and neurological outcomes identify (1) a clinical need to aggressively treat infections in people with risk factors for stroke and (2) the need to understand the mechanism(s) of the association between infections and stroke.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>26463864</pmid><doi>10.1186/s12993-015-0077-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1744-9081
ispartof Behavioral and brain functions, 2015-10, Vol.11 (1), p.32-32, Article 32
issn 1744-9081
1744-9081
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4604642
source PubMed (Medline); Publicly Available Content Database
subjects Affect - drug effects
Animals
Behavior, Animal - drug effects
Behavior, Animal - physiology
Brain Infarction - pathology
Brain Infarction - physiopathology
Brain Infarction - psychology
Cognition - drug effects
Illness Behavior - drug effects
Infarction, Middle Cerebral Artery - pathology
Infarction, Middle Cerebral Artery - physiopathology
Infarction, Middle Cerebral Artery - psychology
Lipopolysaccharides - adverse effects
Male
Mice
Rotarod Performance Test
title Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T12%3A49%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipopolysaccharide%20exacerbates%20infarct%20size%20and%20results%20in%20worsened%20post-stroke%20behavioral%20outcomes&rft.jtitle=Behavioral%20and%20brain%20functions&rft.au=Doll,%20Danielle%20N&rft.date=2015-10-13&rft.volume=11&rft.issue=1&rft.spage=32&rft.epage=32&rft.pages=32-32&rft.artnum=32&rft.issn=1744-9081&rft.eissn=1744-9081&rft_id=info:doi/10.1186/s12993-015-0077-5&rft_dat=%3Cproquest_pubme%3E4016749371%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-8a845a6e6f2b8237333121d17634673a7f2a7c98d1f27d6fa763c33564ec8d2d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1779781220&rft_id=info:pmid/26463864&rfr_iscdi=true